Evidence map›Paper›PMID 32044514›Full record

ArticleBiomaterials2020

HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours.

Libor Kostka, Lenka Kotrchová, Vladimír Šubr, Alena Libánská, Carolina A Ferreira, Iva Malátová, Hye Jin Lee, Todd E Barnhart, Jonathan W Engle, Weibo Cai and 2 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  9. Review
  10. Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.Journal of functional biomaterials · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Libor KostkaInstitute of Macromolecular Chemistry CAS, Department of Biomedical Polymers, Heyrovského Nám. 2, 162 06 Prague 6, Czech Republic.
Lenka KotrchováInstitute of Macromolecular Chemistry CAS, Department of Biomedical Polymers, Heyrovského Nám. 2, 162 06 Prague 6, Czech Republic.
Vladimír ŠubrInstitute of Macromolecular Chemistry CAS, Department of Biomedical Polymers, Heyrovského Nám. 2, 162 06 Prague 6, Czech Republic.
Alena LibánskáInstitute of Macromolecular Chemistry CAS, Department of Biomedical Polymers, Heyrovského Nám. 2, 162 06 Prague 6, Czech Republic.
Carolina A FerreiraDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States.
Iva MalátováInstitute of Microbiology CAS, Laboratory of Tumour Immunology, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Hye Jin LeeDepartment of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Todd E BarnhartDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, United States.
Jonathan W EngleDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, United States.
Weibo CaiDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI, United States; Department of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI, United States; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, United States; University of Wisconsin, Carbone Cancer Center, Madison, WI, United States.
Milada ŠírováInstitute of Microbiology CAS, Laboratory of Tumour Immunology, Vídeňská 1083, 142 20 Prague 4, Czech Republic.
Tomáš EtrychInstitute of Macromolecular Chemistry CAS, Department of Biomedical Polymers, Heyrovského Nám. 2, 162 06 Prague 6, Czech Republic. Electronic address: etrych@imc.cas.cz.
Czech Academy of Sciences, Institute of Macromolecular Chemistry · CZUniversity of Wisconsin–Madison · USCzech Academy of Sciences, Institute of Microbiology · CZ

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

Design, controlled synthesis, physico-chemical and biological characteristics of novel well-defined biodegradable star-shaped copolymers intended for advanced drug delivery is described. These new biocompatible star copolymers were synthesised by grafting monodispersed semitelechelic linear (sL) N-(2-hydroxypropyl)methacrylamide copolymers onto a 2,2-bis(hydroxymethyl)propionic acid (bisMPA)-based polyester dendritic core of various structures. The hydrodynamic diameter of the star copolymer biomaterials can be tuned from 13 to 31 nm and could be adjusted to a given purpose by proper selection of the bisMPA dendritic core type and generation and by considering the sL copolymer molecular weight and polymer-to-core molar ratio. The hydrolytic degradation was proved for both the star copolymers containing either dendron or dendrimer core, showing the spontaneous hydrolysis in duration of few weeks. Finally, it was shown that the therapy with the biodegradable star conjugate with attached doxorubicin strongly suppresses the tumour growth in mice and is fully curative in most of the treated animals at dose corresponding approximately to one fourth of maximum tolerated dose (MTD) value. Both new biodegradable systems show superior efficacy and tumour accumulation over the first generation of star copolymers containing non-degradable PAMAM core.

Indexed as

Biocompatible MaterialsPharmaceutical PreparationsAcrylamidesAnimalsCell Line, TumorDoxorubicinDrug CarriersDrug Delivery SystemsMethacrylatesMicePolymersAcrylamidesBiocompatible MaterialsDoxorubicinDrug Carriershydroxypropyl methacrylateMethacrylatesN-(2-hydroxypropyl)methacrylamidePharmaceutical PreparationsPolymersbisMPACancerDoxorubicinDrug deliveryHPMAStar-like polymers

Identifiers

PMID32044514
PMCPMC7123463
OpenAlexW2996789895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.